The risk of malignancy and its incidence in early rheumatoid arthritis patients treated with biologic DMARDs
Treatment with disease-modifying anti-rheumatic drugs (DMARDs) has raised concerns about the risk of malignancies in rheumatoid arthritis (RA) patients. However, the association between biologic DMARDs (bDMARD...
Source: Arthritis Research and Therapy - Category: Rheumatology Authors: Soo-Kyung Cho, Jiyoung Lee, Minkyung Han, Sang-Cheol Bae and Yoon-Kyoung Sung Tags: Research article Source Type: research